NPR News Now: January 31, 2025, 9 AM EST
1. Tragic Mid-Air Crash Near Washington D.C.
Timestamp [00:16 - 01:24]
In a devastating event, a regional American Airlines jet collided mid-air with a military helicopter over the Potomac River near Washington D.C., resulting in the loss of 67 lives. Search and rescue operations are ongoing, with dozens of bodies recovered to date. Among the victims were six members of an elite figure skating club from Boston, accompanied by their parents and coaches.
Becky Sullivan reports on the scene:
Becky Sullivan [00:43]: "Wichita had just hosted the U.S. Figure Skating Championships, which ran through last Sunday. After the competition, US Figure Skating had held a developmental camp for promising young skaters..."
Doug Zeghibe, head of the Skating Club of Boston, expressed the club's devastation:
Doug Zeghibe [01:00]: "I think our current members, leaders, management team, I don't know what the word is. Is it wrecked? Is it devastated? Folks are just stunned by this."
The tragedy has deeply affected the figure skating community, with the loss of young talents and dedicated coaches underscoring the profound impact of the crash.
2. Trump's Project 2025 Influences Early Executive Actions
Timestamp [01:24 - 02:11]
Despite President Donald Trump's initial denials, elements of the conservative policy agenda known as Project 2025 are emerging in his early executive actions. This includes an order to pause federal funding, which, although later rescinded, aligns with Project 2025's objectives.
Franco Ordonez explains:
Franco Ordonez [01:47]: "Of course, that order was rescinded, but the idea is came from Project 2025. Also part of Project 2025 was the proposal to end birthright citizenship as well as diversity, equity and inclusion programs."
Project 2025 outlines comprehensive plans to reshape the federal workforce, including measures such as instituting a hiring freeze and reclassifying workers, signaling a significant shift in federal policies and priorities.
3. Robert F. Kennedy Jr. Faces Scrutiny Over Vaccine Views
Timestamp [02:11 - 03:13]
Robert F. Kennedy Jr., President Trump's nominee for Secretary of Health and Human Services, endured a challenging Senate confirmation hearing focused on his stance on vaccines. Senator Angela Brooks confronted Kennedy regarding his past statements suggesting different vaccine schedules for Black and White individuals.
During the hearing, Kennedy struggled to provide a clear response:
Robert F. Kennedy Jr. [02:41]: "So what different vaccine schedule would you say I should have received?"
He referenced research from the Mayo Clinic and an anti-vaccine advocacy film produced by his organization, though experts from the Mayo Clinic clarified that their studies do not support claims of increased vaccine side effects or vulnerabilities among African Americans.
4. Appeals Panel Upholds New York’s Voting Rights Act
Timestamp [03:13 - 04:02]
An appeals panel has overturned a state appeals court's decision that deemed New York's Voting Rights Act unconstitutional. The initial ruling had argued that the state's protections against racial discrimination in voting violated the U.S. Constitution's equal protection clause. However, the appeals panel maintained that the law is valid as it allows any racial minority group within a community to file lawsuits if their collective voting power is diluted.
Hansi Lo Wang reports:
Hansi Lo Wang [03:33]: "Eight states have passed state voting rights acts, and advocates are pushing for more as critics of the federal Voting Rights Act of 1965 keep chipping away at that landmark law in court."
This reversal upholds New York's commitment to safeguarding voting rights against racial discrimination amidst ongoing national debates over election laws.
5. FDA Approves New Non-Addictive Pain Medication
Timestamp [04:02 - 04:54]
The Food and Drug Administration (FDA) has approved a groundbreaking non-addictive pain medication developed by Vertex Pharmaceuticals. This new drug is designed to treat pain resulting from injuries or surgeries without the addictive risks associated with opioid painkillers.
Key points include:
- The approval followed two large clinical trials involving approximately 1,000 postoperative patients.
- The medication works by targeting nerves outside the brain, effectively blocking pain signals without entering the brain, thereby eliminating the potential for addiction.
Market Impact:
- Asian markets showed slight gains with Japan's Nikkei and Hong Kong's Hang Seng both up by 0.1%.
- U.S. futures indicated positive momentum, with Dow futures up by 0.2% and Nasdaq futures rising by 0.8%.
Jeanine Herbst concludes:
Jeanine Herbst [04:02]: "The company says it only works on nerves outside of the brain, blocking pain signals and can't get inside of the brain."
This approval marks a significant advancement in pain management, offering a safer alternative for patients and potentially reducing the reliance on addictive opioid medications.
This comprehensive summary captures the key developments from the January 31, 2025, episode of NPR News Now, providing an in-depth overview of the day's most pressing news topics.